Homology modeling

«e¨¥


¥Ñ³J¥Õ½èªºÓi°ò»Ä§Ç¦C¹w´ú¤À¤lªº¤Tºûµ²ºc¬O¤@¤j¬D¾Ô¡C¥Ø«e¹w´ú³J¥Õ½èµ²ºcªº¤èªk¥i¤À¦¨¦³¦P·½¼ÒÀÀªk(Homology Modeling)¡B§éÅ|¿ìÃÑ(Folding Recogition)¡B­«ÀY°_ºâªk(AB initio)¡C

¦P·½©Ê¼ÒÀÀªk(Homology modeling)¤S¥i¥H¥s°µ¤ñ¸û©Ê¼ÒÀÀªk(comparative modeling)©Î¬Oª¾ÃÑ°ò¦¼ÒÀÀªk(knowledge-base modeling)¡CÀ³¥Î³o¤@­Ó¤èªk¥i¥H§Ö³tªº¼ÒÀÀ³J¥Õ½èªº¤Tºûµ²ºc(3D structure)¡C¥Ø²{¤w¦³¤@¨Ç¤H±q¨Æ¬Y¨Çª«ºØ(species)ªº¾ã­Ó°ò¦]Åé³J¥Õ½èµ²ºc¼ÒÀÀ¡C¨Ò¦p­^°êªºxxx¤w¼ÒÀÀ¥X»Ã¥Àµß(yeast)ªº¾ã­Ó³J¥Õ½èµ²ºc¡C

¦P·½¼ÒÀÀªk(Homology Modeling)°ò¥»°²³]¬O³J¥Õ½è¤À¤lµ²ºc¨ã¦³¬YºØ³W«h©Ê¡A¨ä¥i¯à¤Tºûµ²ºcªº°ò¥»§ÎºAºØÃþ¦³­­¡A¦U­Ó§ÎºA¬O¥Ñ´XºØ¯S©wªºÓi°ò»Ä§Ç¦C©Òºc¦¨¡C

¦X²zªº³J¥Õ½è¤À¤l¼Ò«¬¥²¶·º¡¨¬¤U¦C±ø¥ó :

1.¥i¾a ( reliable )
2.«Ü®e©ö©MX¥ú´¹Åé¾Ç¤Î¦hºû«×NMP¥úÃйêÅç¼Æ¾Ú¬Û¤ñ¡C
3.©M³J¥Õ½è¤À¤l²{¦³¤§¹êÅçÆ[´úµ²ªG¤@­P¡A¨Ã¥B©M³J¥Õ½è¤À¤lµ²ºcªº¤@¯ë¯S¼x¬Û²Å¡C
4.´£¨Ñ¨¬°÷¸Ô²Óªº¸ê®Æ¡A¥H¨Ñ¤À¤lµ²ºc©M¥\¯àÃö«Y¬ã¨s¤§¥Î¡C

¦³¤F³J¥Õ½è¤À¤l¤Tºûµ²ºcªº¸ê®Æ¡A«Ø¥ß¦X²zªº¤À¤l¼Ò«¬¤§«á¡A±N¦³§U©ó¤À¤lµ²ºc©M¨ä¥\¯àÃö«Y¤§¬ã¨s¡A¨Ò¦p¦³§U©ó¸ÑÄÀ«ü©w¦ì¸m¤§Ói°ò»Ä§ó´«¹êÅçµ²ªG©M¹êÅ窺³]­p¡A¤j¿çÁY´î¹Á¸Õªº®É¶¡¡C

 


³J¥Õ½è¤À¤lµ²ºcªº¯S¼x

³J¥Õ½è¤À¤lµ²ºcªº¯S¼x:

¤@¯Åµ²ºc

³J¥Õ½è¤À¤lªºÓi°ò»Ä§Ç¦C¡A

¤G¯Åµ²ºc

¤À¤l°©·F(backbone)¨Ì¨ä¬O§_¨ã¦³©úÅã³W«hªººPÅ|¦¡¼Ë¨Ó°Ï¤À:Á³±Û¡A-ºP¤ù©MÂà§é(turn)¡A¤£²Å¦X³o¤TÃþªºµ²ºcºÙ¬°½u°é(coil) ¡C

¶W¤G¯Åµ²ºc ( supersecondary structure )

¤G¯Åµ²ºc¤À¤l¦b¤TºûªÅ¶¡¤º¥H¯S©wªº¤è¦¡±Æ¦C¡Aºc¦¨¸û°ª¼h¦¸µ²ºcªº¯S¼x¡A¬O¥Ñ¤G¯Åµ²ºcªº°ï¿n©M¾ãÅé¯à¶q¦]¯À¨Ó¨M©wªº¡Cex:Greek key motif

¤T¯Åµ²ºc

¤@­Ó©Î¦h­Óµ²ºc°Ï°ì¡Cµ²ºc°Ï°ì¬O«ü³J¥Õ½è¤À¤l¤º¤@±K¶°°ï¿nªº¹Îª¬³¡¥÷¡A¥Ñ³æ¤@¤À¤lÃìºPÅ|¦Ó¦¨¡C

¥|¯Åµ²ºc

¥Ñ¦h­Ó¤À¤lÃì¦U¦Ûºc¦¨ªºµ²ºc³æ¦ì¥H¯S®íªº±Æ¦C¤è¦¡ºc¦¨¨ã¦³¯S©w¥Í¤Æ¥\¯àªº³J¥Õ½è¤À¤lµ²ºc¡C

³J¥Õ½è¤À¤lµ²ºc¡A

©Ò¦³¤ô·»©Êªº¹Îª¬³J¥Õ½è³£¬O±K¶°°ï¿nªºµ²ºc¡A

=> ¤º³¡®Ö¤ßªºÓi°ò»Ä¦h¥b¬O¹½¤ô©Ê

=> ¥~¼h¥Ñ¿Ë¤ô©ÊªºÓi°ò»Ä§Ç¦C¥]³ò¡C

¿Ë¤ô©Ê©M¹½¤ô©ÊÓi°ò»Ä§Ç¦C±Æ¦Cªº¤è¦¡ª½±µ¼vÅT¦C³J¥Õ½è¤À¤l¤T¯ÅºPÅ|ªº¤è¦¡¡C

¹Îª¬³J¥Õ½è¤À¤l¥i¤À¦¨¤­Ãþ¡A

¥þa-Á³±Û¡A¥þb -ºP¤ù¡AaÁ³±ÛBºP¤ù¥æ´À¥X²{(a/b) ¡AaÁ³±ÛbºP¤ù¤À§O±K¶°¦b¤À¤l¤¤¤£¦Pªº°Ï°ì(a+b) ¡A¥H¤Î¤£ÄÝ©ó¥H¤W¥|¶µªºµ²ºc¡C

¹Îª¬³J¥Õ½è¤À¤lªº¤À¤lÃì©Ý¾ëÃö«Y¥iÂk¯Ç¬°¤T­Ó³W«h :

¬Û³sªº¨â¤G¯Åµ²ºc°Ï°ì¦b§Î¦¨¤T¯ÅºPÅ|µ²ºc®É·|¤¬¬Û±µÄ²¡C
BXBªº³s±µ¤è¦¡³q±`¬O²Å¦X¥k¤â©w«h¡C
§t¦³¤G¯Åµ²ºc¤¸¯À¤§¤À¤l¤ù¬q©¼¦¹¤£§t¥æ¿ù©Î§Î¦¨Ã·µ²¡C

Á`µ²¦Ó½×¡A

³J¥Õ½è¤À¤lªºµ²ºc

¥ÑaÁ³±Û©MbºP¤ù²Õ¦¨ªºµ²ºc³æ¦ì¥H¦³­­ªº¤è¦¡°ï¿n±Æ¦C¦¨¸û°ª¼h¦¸ªºµ²ºc¡A³o¨Çµ²ºc¶i¤@¨B§Î¦¨³J¥Õ½è¤À¤lªº¹½¤ô®Ö¤ß¡A¨ä¤¤¤£§t¥ô¦ó¥´§é©Î¦ù®iªº¤À¤l¤ù¬q¡A¥H¤Î¿Ë¤ôªº¥~¼h³¡¥÷¡C

¦PÄݤ@¨t²Î(Family) ªº³J¥Õ½è¤À¤lºc³y¦³¬Û·íµ{«×ªºÃ­©w©Ê¡A¤£·|¦]¨ä¤¤¬Y¨ÇÓi°ò»Äªº³Q¨ú¥N©Î§ó§ï¦Ó¦³¤Ó¤jªº§ïÅÜ¡A¦]¦¹±N¨â¨ã¦³¬Û·í§Ç¦C¬Û¦ü(sequence homology)µ{«×ªºÓi°ò»Ä§Ç¦C¤§¤@°µ­Y¤zÓi°ò»Äªº§ó´«©Î­è´î¡A¨ä¤À¤lµ²ºc¤WªºÃþ¤ñ( stuuctural homology )Ãö«Y¤´µM¦s¦b¡C

¹ï·Ó¦U¤À¤lªºÓi°ò»Ä§Ç¦C¥i¥Hµo²{¡A¦b¦PÃþ³J¥Õ½è¤À¤l¤¤³£·|¥X²{ªºÓi°ò»Ä§Ç¦C¤ù¬q±`ºc¦¨µ²ºc¤Wºû«ù¤£Åܪº°Ï°ì¡A¦ÓÅܲ§¸û¤jªº¹ïÀ³§Ç¦C¤ù¬q«hºc¦¨¤À¤lµ²ºc¤À¤lµ²ºc¤W®t²§ªº°Ï°ì¡C

³J¥Õ½è¤À¤l®Ö¤ß³¡¤Àªº¤À¤l°©·F¥Ñ¤G¯Åºc³y±K¶°°ï¿n¦Ó¦¨(¤£¥]§tÃP´²ªº¤À¤lÃì)¡C¥Ñ©ó¦P¤@¨t²Îªº³J¥Õ½è¤À¤l¨ã¦³¬Û¦Pªº¤T¯ÅºPÅ|¦¡¼Ë¡A¦b®Ö¤ß¤À¤l°©·F¤W¨ä¨ã¦³¤Ö¶qÓi°ò»Äªº§ó´«©Î®t²§¡A¤£·|¼vÅT¨ì¤T¯ÅºPÅ|ªº¤@¯ë¯S¼x¡A¦ý·|§ïÅܳJ¥Õ½è¤À¤l­Y¤zª«²z¤Æ¾Ç¯S©Ê¡A¦p®Ö¤ß³¡¥÷¬O°ª«×¹½¤ô©Êªº¡C

 


¦P·½¼ÒÀÀªk¹w´ú³J¥Õ½è¤À¤lµ²ºc

¥¦¥D­nªº¤è¦¡¬O§Q¥Î²{¦s¤w¸Ñ¥Xªºµ²ºc(¥i¯à¥Ñ®ÖºÏ¦@®¶(NMR)©Î¬OX¥ú¶®g(X-ray diffraction)©Ò¸Ñ¥Xªºµ²ºc)¬°¼ÒªO¡A¼ÒÀÀ¥X·Q­n¸Ñªº¥¼ª¾µ²ºc³J¥Õ½è§Ç¦C (protein sequence)¡C¥¦¸Ô²Óªº¤èªk¦C¦b¤U­±¡C¤@¯ë¨Ó»¡¡A·í©Ò­n¸Ñªº³J¥Õ½è§Ç¦C(target protein)©M¼ÒªO(template)¶¡ªº¬Û¦ü©Ê¶V°ª¡A©Ò¼ÒÀÀ¥X¨Óªºµ²ºc¥¿½T©Ê¡B¥i«H«×¤]´N¶V°ª¡C

«Ø¥ß³J¥Õ½è¤À¤l¼Ò«¬ªºµ{«×¥i¤À¦¨¤»­Ó¨BÆJ:

¿ï¾Ü°Ñ¦Ò³J¥Õ½è¤À¤l¡C
±N¥Ø¼Ð¤À¤l©M°Ñ¦Ò¤À¤lªºÓi°ò»Ä§Ç¦C¹ï»ô¡C
«Ø¥ß¥Ø¼Ð¤À¤l®Ö¤ß³¡¥÷ªº¤À¤l°©·F¡C
²£¥Í¦Uµ²ºc¦uùڰϰ줧¶¡ÃP´²¤À¤lÃ쪺µ²ºc¡C
¥Ø¼Ð¤À¤lµ²ºc­×¥¿·L½Õ¡C
¤Tºû¤À¤lµ²ºcªºÀËÅç©MÃÒ¹ê¡C

 


¨BÆJ(1)--¿ï¾Ü©M¥Ø¼Ð³J¥Õ½è¤À¤l¬ÛÃöªº°Ñ¦Ò³J¥Õ½è¤À¤l¡C

¦Ò¼{¨â­Ó±ø¥ó :

¥Ø¼Ð¤À¤l©M°Ñ¦Ò¤À¤l¶¡§Ç¦C¬Û¦üªºµ{«×¡A

°Ñ¦Ò³J¥Õ½è¤À¤l¤wª¾µ²ºcªº·Ç½T©Ê¡C

­Y¥Ø¼Ð³J¥Õ½è¤À¤l©ÒÄݪº¨t²Î¤¤¦³¤@­Ó¥H¤Wªº¤À¤l¦³¤wª¾µ²ºc¡A¨Ã¥B©M°Ñ¦Ò¤À¤lªº§Ç¦CÃþ¤ñµ{«×¦b25%¥H¤W®É¡A¤@¯ë¦Ó¨¥¥i¥Î¦P·½©Ê¼ÒÀÀ¤èªk±o¨ì¥Ø¼Ð¤À¤lªº¦X²z¼Ò«¬¡C

­Y¨S¦³ºë½Tµ²ºcªº³J¥Õ½è¤À¤l¥i¨Ñ°Ñ¦Ò¡A©Î§Ç¦CÃþ¤ñµ{«×§C©ó25%¡A¥HÃþ¤ñ¤èªk¨Ó«Ø¥ß³J¥Õ½è¤À¤l¼Ò«¬¦¨¥\ªº¾÷·|´N¤£°ª¡A¦¹®É»Ý§Q¥Î¨ä¥L¹êÅç¼Æ¾Úªº¨ó§U¡A¨Ò¦p HIV-l( HIV-RT ) ¤¤ reverse transcriptase¡A ( ¤ÏÂà´C) ªº polymerase °Ï°ì¡A°ß¤@¤wª¾µ²ºcªº°Ñ¦Ò³J¥Õ½è¬O E.Coliªº DNA polymerase ( Pol-I ) ¡AÁöµM¨âªÌ§Ç¦CÃþ¤ñµ{«×§C©ó 25% ¡A¦ý¨âªÌ¨ã¦³·¥¬Ûªñªº¥\¯à¦Ó¥B¥Ñ affinity- labelling chemical modification ¹êÅ礤½T»{¥XÃöÁ䪺¹ïÀ³Ói°ò»Älysine¡A´£¨Ñ­«­nªºÃÒ¾Ú¤ä«ù¥H Pol-I ªºµ²ºc°µ¬°«Ø¥ßHIV-RT¼Ò«¬ªº°Ñ¦Ò¤À¤l¡A¦]¬°¥Ø«e¥u¦³Pol-IªºaºÒ­ì¤l®y¼Ð¡A¦]¦¹HIV-RT¼Ò«¬ªº·Ç½T«×¨ü¨ìPol-IaºÒ­ì¤l·Ç½T«×ªº¼vÅT¡C

 

¨BÆJ(2)--¤ñ¹ï¥Ø¼Ð©M°Ñ¦Ò³J¥Õ½è¤À¤lªºÓi°ò»Ä§Ç¦C¡C

³o¬O¾ã­Óµ{§Ç¤¤³ÌÃöÁä©Êªº¨BÆJ¡A¹ï»ô¨â¤À¤lÓi°ò»Ä§Ç¦C§Y¨M©w¥Ø¼Ð¤À¤l§Ç¦C¤¤¹ïÀ³©ó®Ö¤ß¤À¤l°©·F¤ÎÃP´²¤À¤lÃ쪺¦U­Ó¬q¸¨¡A¹ï²£¥Í¥¿½T¤Tºûµ²ºc¦³ÃöÁä©Êªº¼vÅT¡C

·í§Ç¦C¬Û¦üµ{«×¤j©ó50% ®É¡A«Ü®e©ö±N¨â§Ç¦C¹ï»ô¡C¬Û¦üµ{«×§C©ó50%®É¡A«h»Ý¤@¨ÇÃB¥~ªº¸ê®Æ¤~¯à±o¨ì¥i¾aªº¹ï»ô§Ç¦C¡A§xÃø¤§³B¦b©ó½T»{§Ç¦C¤¤¾A·íªº°ò·ÇÂI¡C³o°ò·ÇÂI¥²¶·³£¦s¦b©ó°Ñ¦Ò©M¥Ø¼Ð³J¥Õ½è¤À¤l¼ÐÓi°ò»Ä§Ç¦C¤§¤¤¡A¨Ã¨ã¦s¦bµ²ºc©M¥\¯à¤Wªº­«­n©Ê¡A³o¨Ç°ò·ÇÂI´£¨Ñ¨â³J¥Õ½è¤À¤l¥¿½Tªºµ²ºc¹ïÀ³Ãö«Y¡A§ä´M°ò·ÇÂIªº¤èªk¦³´XºØ:

±N°Ñ¦Ò¤Î¥Ø¼Ð¤À¤l»P¦P¤@¨t²Î¤º¨ä¥L³J¥Õ½è¤À¤l§Ç¦C±Æ¦C¤ñ¹ï¡A¥H¦U¤À¤l§Ç¦C¹ïÀ³¬Û¦P§Ç¦C¬q¸¨°µ¬°°ò·ÇÂI

±N¼Æ­Ó¥i¯àªº°Ñ¦Ò¤À¤lªºµ²ºc­«Å|¡A½T»{¥XÂù²¸Áäcystein ªº¦ì¸m

¶i¦æ¯S©w¦ì¸mªºÓi°ò»Ä§ó´« ( site-directed mutagenesis ) ¦b°Ñ¦Ò©M¥Ø¼Ð³J¥Õ½è¤À¤l°µ affinity-labelling chemical modification¹êÅçµ¥µ¥¡A³£¦³§U©ó°ò·ÇÂIªº½T»{¡C

¦b¹ï»ô¨âÓi°ò»Ä§Ç¦C®É¡A¥u¦³¦bÂà§é (turn ) ¤ÎÃP´²¤À¤lÃì ( 1oop ) ªº°Ï°ì¤º¤~¥i¶i¦æÓi°ò»Ä¬q¸¨ªº´¡¤J¡B§R°£©M§ó´«¡A¹½¤ô©ÊªºÓi°ò»ÄÀ³­­¨î¦b³J¥Õ½è¤À¤l®Ö¤ß³¡¥÷ªº¤À¤l°©·F¤W¡C

 

¨BÆJ(3)--²£¥Í¥Ø¼Ð¤À¤l®Ö¤ß³¡¥÷ªº¤À¤l°©·F¡C

§Q¥Î°Ñ¦Ò¤À¤lªº®Ö¤ß³¡¥÷¤À¤l°©·Fªºµ²ºc¬°°ò¦¡A±NÓi°ò»Ä´«¦¨¥Ø¼Ð¤À¤l¹ïÀ³¦ì¸mªºÓi°ò»Ä¡C

®Ö¤ß³¡¥÷¤À¤l°©·FªºÓi°ò»Äªº§ó´«¥u·|¬FÅܤG¯Åµ²ºc¤¸¯Àªº¬Û¹ï¦ì¸m©M¨ú¦V¡A¦Ó¤£­P©ó¯}Ãa³o¨Çµ²ºc¤¸¯À©Î¤T¯ÅºPÅ|ªº¤@¯ë¯S©Ê¡A¦Ó¥B¦b³o­Ó°Ï°ì­n°µªºÓi°ò»Ä´¡¤J©Î§R°£ªº¾÷·|«Ü¤p¡A­×§ï«á¥i¦A§Q¥Î¦ì¯à¨ç¼Æ¨Ó½Õ¾ã¦UÓi°ò»Äªº¦ì¸m¡C¬°¤FÁקK³y¦¨¤À¤l®Ö¤ß³¡¥÷¤À¤l°©·Fµ²ºcªº­«¤j§ïÅÜ¡A³o³¡¥÷ªº­×§ï¬O³v¨B¶i¦æªº¡A¤@­Ó¤@­ÓÓi°ò»Ä¤À§O³B²z¡C¦b»Ý­n¶i¦æÓi°ò»Ä´¡¤J©Î§ó´«®É¡A¦P®É­n¨M©w¸ÓÓi°ò»Ä¤äÃ쳡¥÷ªº¤À¤lºc§Î¡C°µÓi°ò»Ä§ó´«®É¡A³Q§ó´«Ói°ò»Ä¤äÃ쳡¥÷ªº¤@­Ó©Î¦h­Ó§á¨¤xªº­È¬O±Ä¥Î­ì°Ñ¦Ò¤À¤â¹ïÀ³Ói°ò»Ä¤äÃ쳡¥÷ªº¹ïÀ³§á¨¤­È¡A¤äÃ줤¨ä¥L³¡¥÷ªº§á¨¤­È«h¥Ñ³J¥Õ½èµ²ºc¸ê®Æ®w¤¤§ä´M³Ì¦X²zªº­È¥N¤H¡C¦b´¡¤JÃB¥~Ói°ò»Ä®É¡AÓi°ò»Ä¤äÃ쳡¥÷ªº©Ò¦³§á¨¤³£­n«ü©w¾A·íªº¼Æ­È¡A·í©Ò¦³­ì¤l³£¦³«ü©wªº®y¼Ð­È¤§«á¡A¦A¥H¤À¤l¤O¾Ç¤èªk¯à¶q³Ì¤p¤Æµ{§Ç®ø°£¥i¯àªº­ì¤l­«Å|ªº±¡ªp¡C

 

¨BÆJ(4)--²£¥ÍÃP´²¤À¤lÃ쳡¥÷ªºµ²ºc¡A

¨âºØ¤èªk¡A

¸ê®Æ®wùØ·j´M¨ã¦³¬Û¦PÓi°ò»Ä§Ç¦Cªº¤ù¬q¨Ã­É¥Î¨ä®y¼Ð¸ê®Æª½±µ¥N¤H

§Q¥Î¯à¶q¯à­pºâ¤èªkª½±µ²£¥Í¦X²zªº­ì¤l®y¼Ð¡C

¸ê®Æ®w·j´Mªº¤èªk¡A¯à²£¥Íµu¤À¤lÃì ( 4-6 ­ÓÓi°ò»Ä ) ©Î¥Ñ­«½Æ¥X²{ªº°ò¥»µ²ºc¦¡¼Ëºc¦¨ªº¤¤µ¥¤j¤pªº¤À¤lÃ줧µ²ºc¡C¾A¥Î½d³ò¨ü­­©ó³J¥Õ½èµ²ºc¸ê®Æ®w¤º¤wª¾µ²ºcªº¼Æ¶q¡BºØÃþ©M¦h¼Ë©Ê¡C¤p¬qªº¤À¤l§Ç¦C¥»¨­§Y¨ã¸û¤pªº¤À¤lºc«¬ªÅ¶¡¡A¨Ã¥B¥X²{ªº¾÷·|¸û¦h¡A¤ñ¸û¾A¦X³oºØ¤èªk¡C

¯à¶q­pºâ¤èªkª½±µ¦ôºâ³o¤À¤l¤ù¬q¥i¥Îªº¤À¤lºc§ÎªÅ¶¡¤¤­«­nªº°Ï°ì¡A¥H¨t²Î¦¡©ÎÀH¾÷¦¡ªºµ{§Ç¶i¦æ¤À¤lºc§Î·j´M¡A¥Î³oºØ¤è¦¡¥i³B²z¨ìªø«×¬°9ªºÓi°ò»Ä§Ç¦C¡A¨Ã¥B¥i²£¥Í©M¤wª¾¬Û¦üµ²ºc¥H¥~ªº¤À¤lºc§Î¡A¼W¥[µ²ºcªº¦h¼Ë©Ê¡C³B²z¸ûªøªº¤À¤lÃì®É¡A¥Ñ©ó¨t²Î¤Æªº¤À¤lºc§Î·j´M¤¤¦U¦Û¥Ñ«×±Æ¦C²Õ¦X²£¥Í·¥¤jªººc§ÎªÅ¶¡¡A¯à¶q­pºâ¤èªk»Ý­n«Ü¤jªº­pºâ¸ê·½¡C¬°¤F­°§C­pºâ¶q¡A³o³¡¥÷ªº­pºâ¥i¤À¦¨¨â­Ó¶¥¬q¡A

²Ä¤@­Ó¶¥¬q¤¤¥ý©¿²¤¤£­pÓi°ò»Äªº¤äÃ쳡¥÷ ( glycine ©M proline ªº¤äÃ쳡¥÷«O¯d¨ìB-ºÒ­ì¤l¬°¤î ) ¡A §Y¬Ò·í§@ alanine ³B²z¡A¥ý¦b³o¤À¤l°©·Fªº¤À¤lºc§ÎªÅ¶¡¤º°µ¯à¶q³Ì¤p¤Æ­pºâ¡A§ä¨ì¦X²zªº¤À¤l°©·Fºc§Î«á¡A

²Ä¤G¶¥¬q¤¤±N¤äÃ쳡¥÷µ²ºc¦Ò¼{¶i¨Ó¡A¥H¯à¶q³Ì¤p¤Æªº¤è¦¡­pºâ¦U¤äÃ쳡¤Àªº¤À¤lºc§Î¡C¦b°µ¯à¶q³Ì¤p¤Æ­pºâ®É¡A¬°¤F¦Ò¼{¾Fªñ¤äÃ쳡¥÷ªº¼vÅT¡A»Ý±N©Ò¦³¤äÃì¦P®É³B²z¡C¬°«OÃÒ±o¨ì¾A·íªº§C¯à¶q¤À¤lºc§Î¡A¥i¥Î¼ÒÀÀ°h¤õªk ( Simulated Annealing ) ¡A

¦]³J¥Õ½è¤À¤l¸ûÃP´²³¡¥÷ªº¤À¤lÃì¥X²{¦b¤À¤lªºªí¼h³¡¥÷¡A¦b¨M©w³o³¡¥÷¤À¤lºc§Î®É­n¦Ò¼{©M·»¾¯¤À¤lªº§@¥Î¡C

¹ê»Ú¤W¡A¸ê®Æ®w·j´M©M¯à¶q­pºâ¤èªk¬O¦X¨Ö¨Ï¥Îªº¡C¥ý¥Ñ¸ê®Æ®w´£¨Ñªñ¦üªºµ²ºc¦A¥H¯à¶q³Ì¤p¤Æ©Î¤À¤l¹B°Ê¤èªk°µ½Õ¾ã¡C¦b·j´Mªº¹Lµ{¤¤¤]¥i¥[¤H¯à¶qªº­pºâ¥H¼W¥[·j´Mªº®Ä²v¡C

 

¨BÆJ(5)--­×¥¿³Ì«áªº¤À¤lµ²ºc¡C

¦b²£¥ÍÃP´²³¡¥÷ªº¤À¤lÃìµ²ºc¶¥¬q¥i¯à±o¨ì¼Æ­Ó¦X²zªº¤À¤lºc§Î¡A­Y¤£¤î¤@¬qªº¤À¤lÃì¦U¨ã¦³´XºØ¥i¯àªº¤À¤lºc§Î¡A«h­n¦Ò¼{¦U¬q¸¨¤À¤lºc§Îªº²Õ¦Xºc§Î¡A¦A¶i¦æ¾ãÅ骺µ²ºc½Õ¾ã©M­×¥¿¡C­YÃP´²³¡¥÷ªºµ²ºc¨Ó¦Û¸ê®Æ®w¡A¸ê®Æ®w²{¦sªº¸ê®Æ¥i¯àµLªk¾A·í¥Nªí¥i¥Îªº¤À¤lºc§ÎªÅ¶¡¡A¦]¦¹­n¦b³o­Ó¶¥¬q§Q¥Î¤À¤l¹B°Ê¾Ç¤èªk¨Ó­×§ï¤À¤lµ²ºc¡A¨Ã­É¦¹¿ë¥X¯à¶q³Ì§Cªº¤À¤lºc§Î¡C

 

¨BÆJ(6)--³J¥Õ½è¤À¤lµ²ºcªºÅçÃÒ

©Ò«Ø¥ß¤À¤l¼Ò«¬ªº¥¿½T©Ê¥²¶·©M¸Ó³J¥Õ½è¤wª¾ªº¹êÅç¼Æ¾Ú°µ¤@­P©Êªº¤ñ¸û¨Óµû¦ô¡A¨Ò¦p·»¾¯¤À¤lªº¥i±µÄ²©Ê¡AÓi°ò»Ä°ï¿n±K«×¡B¹½¤ô©Ê©Î±a¹q²ü©Î·¥©ÊÓi°ò»Äªº¦ì¸m¡A¤À¤lÀR¹q¦ì³õ¤À§G©M·»¸Ñ¦Û¥Ñ¯àµ¥µ¥¹êÅç´ú¶q­È¡C¥t¥~¥Î¤À¤l¹B°Ê¾Ç¤èªk¨Ó±´´ú¬O§_©Ò±o¨ìªº¤À¤lºc§Î¬O°±¯d¦bí©wªº¯à¶q³Ì¤pªº°Ï°ì©Î¬O°±¯d¦b«Ü²Lªº§½³¡¯à¶q³Ì¤p°Ï°ì ¡A ¥Ñ epitope mapping¡A site-specific mutagenesis¡A affinty-labelling chemical modificationµ¥¹êÅç©Ò±oªº¹êÅç¼Æ¾Ú¤]¦³§U©óÀËÅç¹w´úªº¤À¤l¼Ò«¬¬O§_¦X²z¡A

¥H¤W³o¤»­Ó¨BÆJ¬O¤@­Ó¶g´Á¡A¤@¯ë¦Ó¨¥»Ý­n¤ÏÂдX¦¸ªº¹w´ú©M®Õ¥¿ÀËÅ窺µ{§Ç¡A³Ì«á¤~±o¨ì¥i¾aªº¤À¤l¼Ò«¬¡C

 

 

µ²½×


¦P·½©Ê«Ø¼Ò¤èªk¹w´ú³J¥Õ½è¤À¤lªº¤Tºûµ²ºc¡A¦³¨ä­­¨î:

1. ³J¥Õ½è¤À¤l¤¤¥i¨Ñ§@°Ñ¦Òªº³J¥Õ½èµ²ºc¤Î¦¡¼Ëªº¦h¼Ë©Ê«Ü¦³­­¡C

2. ¦b¦P·½©Ê«Ü§C®É¡A¨âÓi°ò»Ä§Ç¦C¤ñ¹ï¡A¥H¤Î¦bÃP´²¤À¤lÃ쳡¥÷ªº¤Tºû

µ²ºc¼ÒÀÀ³£¦³«Ý¶i¤@¨B§ï¶i©Mµo®i¡A

3. ¦b²¤Æ¦ì¯à¨ç¼Æ¤Î´£¨Ñ­pºâ®Ä²v¤Î³B²z·»¾¯®ÄÀ³¤è­±¤´¦³«Ý§V¤O¡C

 

À³¥Î:

¦¹¤@­Ó¤èªk¥i¥HÀ³¥Î¦b³J¥Õ½è¬ðÅܬã¨s(mutation)¡A¬¡©Ê¦ì¸m¬ã¨s(active site)¡AÃĪ«³]­pµ¥¡C¯à°÷´î¤Ö¦b¹êÅç¤W¡B»sÃĤW©Ò¶·ªº®É¶¡¡C

 

cf:­«ÀY°_ºâªk(AB initio)¡C

¥ýÅ禡ªº¤èªk¤£¨Ï¥Î¤wª¾³J¥Õ½è¤À¤lªºµ²ºc¸ê®Æ¡A¦Ó¬O§Q¥Î¸gÅ禡ªº¦ì¯à¨ç¼Æ¡A¥Ñ­pºâ²Õ¦¨­ì¤l¶¡¤§¦UºØ¬Û¤¬§@¥Î¡A±q­ì¤lªº¼h¦¸¤W¼ÒÀÀ³J¥Õ½è¤À¤l¦b¤ô·»²G¤¤¤§¦æ¬°¡A§Q¥Î¯à¶q³Ì¤p¤Æ¤èªk­pºâ¥X¦X²zªº³J¥Õ½è¤À¤l¤Tºûµ²ºc¡C³o¤èªkªºÄY­«¯ÊÂI¬O¦b¤À¤lªººc«¬ªÅ¶¡¤º¦s¦b¦h­Ó¯à¶q¸û¤p­Èªºª¬ºA¡A¥Ñ©ó¤À¤l¨t²Îªº¦Û¥Ñ«×¤Ó¦h¡A¥H­P¦b¤À¤lºc§Îªº¯à¶q¦±­±¤W¦s¦b³\¦h§½³¡¯à¶q³Ì¤pªº¤À¤lºc«¬¡C¯à¶q³Ì¤p¤Æ¤èªk¥»¨­¤£¯à«OÃÒ§ä¨ì¥þ°ìªº¯à¶q³Ì¤pºc«¬¡A¦]¦¹¥²»Ý¥[¤W¨ä¥L»²§U¤èªk¡A¦p²¤Æ­×§ï¦ì¯à¨ç¼Æ¡A»X¦a¥dù¤èªk¡A¼ÒÀÀ°h¤õµ{§Çµ¥µ¥¡A¥H¹Á¸Õ¥h§JªA¦h­«³Ì¤p­È°ÝÃD¡A³o¤è­±ªº§ï¶i©M¹Á¸Õ¤´¬O¬¡ÅDªº¬ã¨s½ÒÃD¡A¦³«Ý¶i¤@¨Bµo®i¡C

 

Reference

1.³J¥Õ½è¤À¤l¤Tºûµ²ºc¹w´ú¤èªk-Ãþ¦¹¤èªk ( Homology ) ²¤¶
­ì§@ªÌ:
Gerald M. Maggiora, S.Lakshmi Narasimhan, Cindy A. Granatir, James R. Blinn,
Joseph B. Moon
§ï¼gªÌ: ¦ó´¼¶¯

2.¥Íª«§Þ³N¤èªk¡A¨÷¥|¡A¥Íª«¸ê°T¾Ç®}·½®õ¡B·¨¥Ã¥¿

3. Nature Structural Biology 7, 986 - 990 (2000)

4. Annu. Rev. Biophys. Biomol.Struct. 2000. 29:291-325

5. http://www.cmbi.kun.nl/gvteach/hommod/index.shtml

6. http://www.expasy.org/swissmod/SWISS-MODEL.html